Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Buzz on the Bullboards: Defending Voter Rights

Stockhouse Editorial
8 Comments| October 22, 2020

{{labelSign}}  Favorites

(Image via @porkchopchili.)

There is one burning topic among Stockhouse’s Bullboards of late … the showdown for the White House.

Early voting is underway in the US for what is a presidential election for the ages and as we all know, there has been some controversy over people’s ability to cast their votes.

Datametrex AI Ltd. (TSX-V: DM, Forum) is providing technology support for the campaign against intimidation of US electoral voters through its subsidiary Nexalogy. Though the election is still 12 days away, early voters have spoken about having their mail-in ballots stolen or extremely long lines at advance polling stations.

Monitoring social media and other online activity, incidents like this will be targeted by Nexalogy’s platform to collect data.

PyroGenesis Canada Inc. (TSX-V: PYR, Forum) continues to gather investor attention after the company had revised its agreement with Mackie Research Capital Corporation to upsize of its bought-deal short form prospectus offering of units to a total of $12 Million. The financing will go towards the company’s ongoing efforts to develop, manufacture, and commercialize its advanced plasma processes and products.

In other tech news, leading provider of high-performance analog semiconductor products for broadband connectivity markets, Spectra7 Microsystems Inc. (TSX-V:SEV, Forum) announced this week that it is entering into the hot 5G mobile infrastructure market. The Company’s new GC2801 product will support extended temperature range requirements for ruggedized outdoor 5G network deployments.

5G’s rollout may have felt like a pipe dream for some, but with so many people working remotely, even outdoors, its adoption is becoming more critical for a lot of businesses. This brings us to this week’s investor pulse poll question: 5G, do you think we need it now? Let us know your thoughts by clicking on the poll image below.

(Click the image to cast your vote.)

Taking a look at last week’s poll, it seems a solid majority of you savvy traders like to make sure you know exactly what you’re getting into when you make your investment. Though nearly a quarter of responders admit they like to “go in blind” or are very forgiving when they find out how a company has performed in the past.

What the "Buzz"

Our Bullboards have up to 2 Million pageviews a day. Get the inside scoop on conversations around the most significant trends and stock appreciations in our weekly wrap up.

Get "Buzz on the Bullboards" delivered to your inbox every Thursday!

Buzz on the Bullboards | Sign Up Here

A global provider of gas generation, purification and filtration solutions for the industrial, energy and renewables marketplace, Xebec Adsorption Inc. (TSX-V: XBC, Forum) recently announced two key management hires:

Its first Vice President, Legal Affairs & Corporate Secretary Nathalie Théberge and its first Vice President, Industrial Russell Warner. Both have extensive experience in the renewable energy industry.

Bombardier Inc. (TSX: BBD , Forum), ever a magnet for trader attention, for better or worse, has seen its share price struggle over the past year, but is still working to return its stock value to its range seen a year ago. BBD just signed a three-year extension to its Train Services Agreement with the UK’s Arriva CrossCountry to maintain, overhaul, service and clean a fleet of 34 class 220 Voyagers and 24 class 221 Super Voyagers. The three-year contract extension is valued at £248 million ($420 million CAD, €273 million euro).

Canadian clean tech company Exro Technologies Inc. (TSX-V: EXRO, Forum) marked a major milestone toward delivering commercial products with in-house design, testing and assembly after launching its Calgary Innovation Centre. The aim is to expand the potential for more strategic partnerships with the Coil Driver technology while also creating a platform for proof of concepts in new research and development projects.

EXRO has only been publicly trading for a month and its share prices has nearly doubled in that time.

(Exro Technologies Inc. stock chart – Sept 22 to Oct 22, 2020. Click to enlarge.)

Meanwhile, Air Canada Inc. (TSX:AC, Forum) shares have been a bargain for investors since March 2020 and like Bombardier, AC wants to get back to a place of prominence in the markets. A stable company with a lot of upside, even during these pandemic times, the company is working to fly high again and recently made its fleet of all-Business Class, Jetz charter aircraft available to customers for commercial flights as it redeploys the fleet on popular winter routes. Each of the airline's four Airbus A319 Jetz aircraft are configured with only 58 North American Business Class seats -- less than half the normal number of seats on this aircraft type -- intending to provide an elevated level of comfort and service.

Canadian cannabis licensed producer Aphria Inc. (TSX: APHA, Forum) just gave its Q1 2020 results with its fiscal first-quarter report and highlighted record gross revenue for adult-use cannabis of $69.6 million in the first quarter, an increase of 23% from prior quarter and the sixth consecutive quarter of growth.

Biopharmaceutical company Theratechnologies Inc. (TSX: TH, Forum) has long been a favourite among Healthcare Bullboarders who have been following its developments to commercialize innovative therapies.

TH also recently released its Q3 2020 financial results and recorded revenues for the nine-month
period ended August 31, 2020 of 46,930, which was $114 more than revenues brought in for the same period a year before.
Theratechnologies’ President and Chief Executive Officer, Paul Lévesque explained that the company recently made a number of key business decisions that are expected to build a stronger foundation for growth.

“First, we announced our intention to pursue the development of tesamorelin for the treatment of NASH in the general population. This well-thought out decision was based on strong scientific evidence and feedback from some of the world’s most renowned experts in this disease area. Additionally, we restructured our sales infrastructure to better align with the current environment and position our commercial medicines for growth. These strategic initiatives, along with our early development efforts in oncology, represent tremendous opportunities for the Company going forward.”

Finally, we highlight Protech Home Medical Corp. (TSX-V: PTQ, Forum), a Cincinnati-based company in the home medical equipment industry that is focused on end-to-end respiratory care. PTQ announced this week that its management team will be presenting and participating in one-on-one meetings at the upcoming Stifel 2020 Virtual Healthcare Conference from November 16th to 18th, 2020.

You can find out more about how to sign up to the conference here.

The company’s Chief Executive Officer and Chairman, Greg Crawford said that the team will be attending virtual conferences regularly throughout the remainder of 2020, given the level of investor interest in the Protech story.

“With a pristine balance sheet, including our newly available $20 million (USD) credit facility with CIT Bank, our continued operational excellence in the midst of the COVID-19 pandemic, and our previously announced LOI that we expect to close imminently, we could not be more excited about the future for Protech.”

Protech provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market, focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions.

We can only capture small fragments of the large dialogue at Stockhouse’s Bullboards, so don’t forget to come back to the Bullboards throughout the week to see how the conversations change. For previous editions of Buzz on the Bullboards: click here.

Get "Buzz on the Bullboards" delivered to your inbox every Thursday!

Buzz on the Bullboards | Sign Up Here

FULL DISCLOSURE: Datametrex AI Ltd. and PyroGenesis Canada Inc. are clients of Stockhouse Publishing.

{{labelSign}}  Favorites